VEGF-A and blood vessels: a beta cell perspective Willem StaelsYves HeremansNico De Leu Review 14 August 2019 Pages: 1961 - 1968
What has zinc transporter 8 autoimmunity taught us about type 1 diabetes? Claire L. WilliamsAnna E. Long Review Open access 23 August 2019 Pages: 1969 - 1976
Reduced size at birth and persisting reductions in adiposity in recent, compared with earlier, cohorts of infants born to mothers with gestational diabetes mellitus Philippa M. PrenticeLaurentya OlgaDavid B. Dunger Article Open access 09 August 2019 Pages: 1977 - 1987
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study Megumi OshimaMin Junon behalf of the ADVANCE Collaborative Group Article Open access 13 July 2019 Pages: 1988 - 1997
In search of causal pathways in diabetes: a study using proteomics and genotyping data from a cross-sectional study Kristina BeijerChristoph NowakLars Lind Article Open access 24 August 2019 Pages: 1998 - 2006
Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey Delia BogdanetCatriona ReddinFidelma P. Dunne Article Open access 04 July 2019 Pages: 2007 - 2016
Persistent effects of in utero overnutrition on offspring adiposity: the Exploring Perinatal Outcomes among Children (EPOCH) study Christine W. HockettKylie K. HarrallDana Dabelea Article 23 August 2019 Pages: 2017 - 2024
Characteristics of familial type 1 diabetes: effects of the relationship to the affected family member on phenotype and genotype at diagnosis Maaret TurtinenTaina Härkönenthe Finnish Pediatric Diabetes Register Article Open access 25 July 2019 Pages: 2025 - 2039
Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice Jorge Postigo-FernandezDonna L. FarberRémi J. Creusot Article 05 September 2019 Pages: 2040 - 2051
Phenotypically distinct anti-insulin B cells repopulate pancreatic islets after anti-CD20 treatment in NOD mice Joanne BoldisonLarissa C. Da RosaF. Susan Wong Article Open access 23 August 2019 Pages: 2052 - 2065
A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial Mads J. SkytteAmirsalar SamkaniThure Krarup Article 23 July 2019 Pages: 2066 - 2078
The proposed systemic thermogenic metabolites succinate and 12,13-diHOME are inversely associated with adiposity and related metabolic traits: evidence from a large human cross-sectional study Senthil K. VasanRaymond NoordamConstantinos Christodoulides Article Open access 15 July 2019 Pages: 2079 - 2087
Loss of arginine vasopressin- and vasoactive intestinal polypeptide-containing neurons and glial cells in the suprachiasmatic nucleus of individuals with type 2 diabetes Rick HogenboomMartin J. KalsbeekChun-Xia Yi Short Communication Open access 20 July 2019 Pages: 2088 - 2093
Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity Leon G. StraubVissarion EfthymiouChristian Wolfrum Article Open access 15 July 2019 Pages: 2094 - 2105
Adenine nucleotide-mediated regulation of hepatic PTP1B activity in mouse models of type 2 diabetes Xiao YangYang ZhaoJianfa Zhang Article 13 August 2019 Pages: 2106 - 2117
Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance Katrien BenhalimaPaul Van CrombruggeChantal Mathieu Article 23 July 2019 Pages: 2118 - 2128
Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease Syamantak MajumderMitchell J. HaddenAndrew Advani Article 09 August 2019 Pages: 2129 - 2142
Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis Andrea Herrero-CerveraÁngela VinuéHerminia González-Navarro Article 06 August 2019 Pages: 2143 - 2157
CD40-targeting KGYY15 peptides do not efficiently block the CD40–CD40L interaction Damir BojadzicPeter Buchwald Letter 09 September 2019 Pages: 2158 - 2160
Diabetes prevention and cardiovascular complications Silvio E. InzucchiCatherine M. ViscoliWalter N. Kernan Letter 14 September 2019 Pages: 2161 - 2162
Diagnostic criteria should be considered when reviewing the effect of diabetes prevention studies Hao LiShen TianLing-quan Kong Letter 13 September 2019 Pages: 2163 - 2165
Correction to: Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register Andri O. SteinarssonAraz RawshaniNaveed Sattar Correction 02 September 2019 Pages: 2166 - 2167